Paris, France

Patrice Debregeas

This inventor holds 12 USPTO granted patents and 1 EPO patent. Top assignees: Laboratoires Des Produits Ethiques Ethypharm, Ethypharm, Inc., Laboratoires Des Products Ethiques Ethypharm. Active years: 1990-2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Patrice Debregeas. Retrieved from https://idiyas.com/inventor/patrice-debregeas

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 3.3

ph-index = 8

Forward Citations = 171(Granted Patents)


Location History:

  • Versailles, FR (1990 - 1995)
  • Paris, FR (1996 - 2004)

Company Filing History:


Years Active: 1990-2004

Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents

Title: Inventor Patrice Debregeas: Innovating Pharmaceutical Solutions

Introduction

Patrice Debregeas is a notable inventor based in Paris, France, with a remarkable portfolio of 12 patents. His contributions to the field of pharmaceutical technology reflect his commitment to innovation and improving healthcare solutions.

Latest Patents

Among his latest inventions is a device for coating granules to be administered orally. This innovative device comprises a drum with peripheral apertures and a feeding member that supplies the drum with the necessary coating or fixing substances. The design features mutually parallel sections that define the apertures, enabling efficient production.

Additionally, Debregeas has developed sustained-release microgranules containing diltiazem as the active principle. These novel microgranules consist of a neutral granular carrier coated with an active layer that includes diltiazem or its pharmaceutically acceptable salt, along with a surfactant and a binder. The outer layer is crucial for ensuring the sustained release of the active principle, significantly enhancing therapeutic efficacy.

Career Highlights

Debregeas has worked with prominent companies such as Laboratoires des Produits Ethiques and Ethypharm, Inc., where he channeled his inventive spirit to develop groundbreaking pharmaceutical products. His experience in these organizations has been instrumental in refining his innovative approaches to drug formulation and delivery.

Collaborations

Throughout his career, Debregeas has collaborated with esteemed colleagues, including Pascal Oury and Pascal Suplie. These partnerships have fostered an environment of creativity and excellence, leading to advancements in pharmaceutical technology and patient care.

Conclusion

Patrice Debregeas exemplifies the spirit of innovation in the pharmaceutical industry. With his extensive patent portfolio and dedication to advancing drug formulation techniques, he continues to make significant contributions that enhance healthcare solutions and improve patient outcomes. His work illustrates the importance of research and collaboration in the pursuit of groundbreaking inventions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…